Multiple-Treatments Meta-analysis of Chemotherapy and Targeted Therapies in Advanced Breast CancerDavide Mauri, John P. A. Ioannidis, Nikolaos P. Polyzos et al.|JNCI Journal of the National Cancer Institute|2008Cited by 524
Evaluating novel agent effects in multiple‐treatments meta‐regressionGeorgia Salanti, John P. A. Ioannidis, Sofia Dias et al.|Statistics in Medicine|2010Cited by 112
Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology GroupElena Fountzilas, G. Koumakis, Sofia Karageorgopoulou et al.|ESMO Open|2020Cited by 38
New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic ReviewAlexia Alexandraki, Anastasia Constantinidou, Elisavet Papageorgiou et al.|Cancers|2023Cited by 17